159
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Preparation and in vitroin vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles

, , , &
Pages 25-36 | Received 26 Dec 2008, Accepted 15 Jan 2009, Published online: 18 Jan 2010

References

  • Aldini NN, Caliceti P, Lora S, Fini M, Giavaresi G, Roca M, et al. Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. J Orthop Res 2001; 19: 955–961
  • Blanco-Prieto MJ, Besseghir K, Orsolini P, Heimgartner F, Deuschel C, Merkle P, et al. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. Int J Pharm 1999; 184: 243–250
  • Blanco MD, Alonso MJ. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 1997; 43: 287–294
  • Body J-J. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone 2002; 30: 75S–79S
  • Chernysheva Y, Babak VG, Kildeeva N, Boury F, Benoit JP, Ubrich N, et al. Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification-solvent evaporation. Mendeleev Comm 2003; 13: 65–68
  • Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Contr Rel 2007; 117: 163–170
  • Dani BA, DeLuca PP. Preparation, characterization and in vivo evaluation of salmon calcitonin microspheres. AAPS PharmsciTech 2001; 2: 22
  • Diaz RV, Llabres M, Evora C. One-month sustained release microspheres of 125I-bovine calcitonin. In vitro–in vivo studies. J Contr Rel 1999; 59: 55–62
  • Dillen K, Vandervoort J, van den Mooter G, Ludwiga A. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006; 314: 72–82
  • Gao P, Ding P, Xu H, Yuan Z, Chen D, Wei J, et al. In vitro and in vivo characterization of huperzine A loaded microspheres made from end-group uncapped poly(D,L-lactide acid) and poly(D,L-lactide-co-glycolide acid). Chem Pharm Bull 2006; 54: 89–93
  • Gaudiano MC, Colone M, Bombelli C, Christolini P, Valvo L, Diociaiuti M. Early stages of salmon calcitonin aggregation: Effect induced by ageing and oxidation process in water and in the presence of model membranes. Biochim Biophys Acta 2005; 1750: 134–145
  • Gennari C. Analgesic effect of calcitonin in osteoporosis. Bone 2002; 30: 67S–70S
  • Hoffart V, Ubrich N, Simonin C, Babak V, Vigneron C, Hoffman M, et al. Low molecular weight heparin-loaded polymeric nanoparticles: Formulation, characterization, and release characteristics. Drug Dev Ind Pharm 2002; 28: 1091–1099
  • Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. J Contr Rel 2002; 79: 137–145
  • Jiao YY, Ubrich N, Marchand-Arvier M, Vigneron C, Hoffman M, Maincent P. Preparation and in vitro evaluation of heparin-loaded polymeric nanoparticles. Drug Deliv 2001; 8: 135–141
  • Johansen P, Corradin G, Merkle HP, Gander B. Release of tetanus toxoid from adjuvants and PLGA microspheres: How experimental set-up and surface adsorption fool the pattern. J Contr Rel 1998; 56: 209–217
  • Law SL, Shih CL. Adsorption of calcitonin to glass. Drug Dev Ind Pharm 1999; 25: 253–256
  • Lee KC, Lee YJ, Song HM, Chun CJ, DeLuca PP. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm Res 1992; 9: 1521–1523
  • Lee KC, Soltis EE, Newman PS, Buron KW, Mehta RC, DeLuca PP. In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres. J Contr Rel 1991; 17: 199–206
  • Lee YH, Sinko PJ. Oral delivery of salmon calcitonin. Adv Drug Deliv Rev 2000; 42: 225–238
  • Lucke A, Kiermaier J, Gopferich A. Peptide acylation by poly(alpha-hydroxy esters). Pharm Res 2002; 19: 175–181
  • Mehta RC, Thanoo BC, DeLuca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly(D,L-lactide-co-glycolide). J Contr Rel 1996; 41: 249–257
  • Munoz-Torres M, Alonso G, Raya MP. Calcitonin therapy in osteoporosis. Treat Endocrinol 2004; 3: 117–132
  • Reginster JY. Treatment of bone in elderly subjects: Calcium, vitamin D, fluor, bisphosphonates. Horm Res 1995; 43: 83–88
  • Sinko PJ, Smith CL, McWhorter LT, Stern W, Wagner E, Gilligan JP. Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats. J Pharm Sci 1995; 84: 1374–1378
  • Tasset Ch, Barette N, Thysman S, Ketelslegers JM, Lemoine D, Preat V. Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin. J Contr Rel 1995; 33: 23–30
  • Tsai T, Mehta RC, DeLuca PP. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption. Int J Pharm 1996; 127: 43–52
  • van Dijkhuizen-Radersma R, Nicolas HM, van de Weert M, Blom M, de Groot K, Bezemer JM. Stability aspects of salmon calcitonin entrapped in poly(etherester) sustained release systems. Int J Pharm 2002; 248: 229–237
  • Yand J, Cleland JL. Factors affecting the in vitro release of recombinant human interferon-gamma (rgIFN-gamma) from PLGA microspheres. J Pharm Sci 1997; 86: 908–914
  • Zaidi M, Inzerillo AM, Moonga BS, Bevis PJR, Huang CL-H. Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 2002; 30: 655–663
  • Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degeneration and release. J Contr Rel 2007; 122: 338–344

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.